These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 18823486)

  • 41. Sublingual misoprostol compared to artificial rupture of membranes plus oxytocin infusion for labour induction in nulliparous women with a favourable cervix at term.
    Lo TK; Lau WL; Wong KS; Tang LC
    Hong Kong Med J; 2006 Oct; 12(5):345-50. PubMed ID: 17028353
    [TBL] [Abstract][Full Text] [Related]  

  • 42. EFFECTIVENESS AND SAFETY OF 2-HOURLY 20 MCG ORAL MISOPROSTOL SOLUTION COMPARED TO STANDARD INTRAVENOUS OXYTOCIN IN LABOUR INDUCTION DUE TO PRE-LABOUR RUPTURE OF MEMBRANES AT TERM: A RANDOMISED CLINICAL TRIAL AT KENYATTA NATIONAL HOSPITAL.
    Mbaluka CM; Kamau K; Karanja JG; Mugo N
    East Afr Med J; 2014 Sep; 91(9):303-10. PubMed ID: 26866082
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Induction of labour in term premature rupture of membranes; oxytocin versus sublingual misoprostol; a randomised clinical trial.
    Pourali L; Saghafi N; Eslami Hasan Abadi S; Tara F; Vatanchi AM; Motamedi E
    J Obstet Gynaecol; 2018 Feb; 38(2):167-171. PubMed ID: 28784054
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vaginal prostaglandin (PGE2 and PGF2a) for induction of labour at term.
    Kelly AJ; Kavanagh J; Thomas J
    Cochrane Database Syst Rev; 2003; (4):CD003101. PubMed ID: 14583960
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparing vaginal and sublingual administration of misoprostol for labour induction in women with intra-uterine fetal death.
    Geels YP; de Gouberville MC; Visser L; van Asten HA
    Trop Doct; 2010 Apr; 40(2):77-80. PubMed ID: 20305098
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sublingual versus vaginal misoprostol for second trimester termination: a randomized clinical trial.
    Tanha FD; Golgachi T; Niroomand N; Ghajarzadeh M; Nasr R
    Arch Gynecol Obstet; 2013 Jan; 287(1):65-9. PubMed ID: 22903515
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Methods to induce labour: a systematic review, network meta-analysis and cost-effectiveness analysis.
    Alfirevic Z; Keeney E; Dowswell T; Welton NJ; Medley N; Dias S; Jones LV; Caldwell DM
    BJOG; 2016 Aug; 123(9):1462-70. PubMed ID: 27001034
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A randomized study comparing the use of sublingual to vaginal misoprostol for pre-operative cervical priming prior to surgical termination of pregnancy in the first trimester.
    Tang OS; Mok KH; Ho PC
    Hum Reprod; 2004 May; 19(5):1101-4. PubMed ID: 15070888
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Misoprostol 50 microg sublingually versus vaginally for labor induction at term: a randomized study.
    Caliskan E; Bodur H; Ozeren S; Corakci A; Ozkan S; Yucesoy I
    Gynecol Obstet Invest; 2005; 59(3):155-61. PubMed ID: 15640607
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A randomized controlled comparison of sublingual and vaginal administration of misoprostol for cervical priming before first-trimester surgical abortion.
    Hamoda H; Ashok PW; Flett GM; Templeton A
    Am J Obstet Gynecol; 2004 Jan; 190(1):55-9. PubMed ID: 14749635
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy and safety of oral and sublingual versus vaginal misoprostol for induction of labour: a systematic review and meta-analysis.
    Pergialiotis V; Panagiotopoulos M; Constantinou T; Vogiatzi Vokotopoulou L; Koumenis A; Stavros S; Voskos A; Daskalakis G
    Arch Gynecol Obstet; 2023 Sep; 308(3):727-775. PubMed ID: 36472645
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Titrated low-dose vaginal and/or oral misoprostol to induce labour for prelabour membrane rupture: a randomised trial.
    Bricker L; Peden H; Tomlinson AJ; Al-Hussaini TK; Idama T; Candelier C; Luckas M; Furniss H; Davies A; Kumar B; Roberts J; Alfirevic Z
    BJOG; 2008 Nov; 115(12):1503-11. PubMed ID: 18752586
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sublingual versus vaginal misoprostol in the management of missed miscarriage.
    Shah N; Azam SI; Khan NH
    J Pak Med Assoc; 2010 Feb; 60(2):113-6. PubMed ID: 20209697
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A randomized trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion at 13-20 weeks gestation.
    Hamoda H; Ashok PW; Flett GM; Templeton A
    Hum Reprod; 2005 Aug; 20(8):2348-54. PubMed ID: 15878927
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Low dose of sublingual misoprostol (12.5 µg) for labor induction].
    Gattás DS; Souza AS; Souza CG; Florentino AV; Nóbrega BV; Fook VP; Amorim MM
    Rev Bras Ginecol Obstet; 2012 Apr; 34(4):164-9. PubMed ID: 22584812
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Overview and expert assessment of off-label use of misoprostol in obstetrics and gynaecology: review and report by the Collège national des gynécologues obstétriciens français.
    Marret H; Simon E; Beucher G; Dreyfus M; Gaudineau A; Vayssière C; Lesavre M; Pluchon M; Winer N; Fernandez H; Aubert J; Bejan-Angoulvant T; Jonville-Bera AP; Clouqueur E; Houfflin-Debarge V; Garrigue A; Pierre F;
    Eur J Obstet Gynecol Reprod Biol; 2015 Apr; 187():80-4. PubMed ID: 25701235
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacokinetics of repeated doses of misoprostol.
    Tang OS; Schweer H; Lee SW; Ho PC
    Hum Reprod; 2009 Aug; 24(8):1862-9. PubMed ID: 19395364
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vaginal misoprostol for induction of labour: a more effective agent than prostaglandin F2 alpha gel and prostaglandin E2 pessary.
    Majoko F; Zwizwai M; Nyström L; Lindmark G
    Cent Afr J Med; 2002; 48(11-12):123-8. PubMed ID: 14562597
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative efficacy and safety of vaginal misoprostol versus dinoprostone vaginal insert in labor induction at term: a randomized trial.
    Ozkan S; Calişkan E; Doğer E; Yücesoy I; Ozeren S; Vural B
    Arch Gynecol Obstet; 2009 Jul; 280(1):19-24. PubMed ID: 19034471
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sublingual versus vaginal misoprostol for the management of missed abortion.
    Tanha FD; Feizi M; Shariat M
    J Obstet Gynaecol Res; 2010 Jun; 36(3):525-32. PubMed ID: 20598032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.